Frank Torti insider trades

Open-market stock purchases and sales by Frank Torti, Director at Immunovant, Inc, from SEC Form 4 filings since Oct 15, 2018.

Recent trades

DateStockTradeValue
Apr 7, 2026IMVT Immunovant, IncBought (not open market)—
Apr 7, 2026IMVT Immunovant, IncBought (not open market)—
Mar 31, 2026ROIV Roivant Sciences LtdSold (not open market)$4.4M
Feb 23, 2026ROIV Roivant Sciences LtdSold$16.2M
Feb 23, 2026ROIV Roivant Sciences LtdBought (not open market)—
Feb 20, 2026ROIV Roivant Sciences LtdSold$27.5M
Feb 20, 2026ROIV Roivant Sciences LtdBought (not open market)—
Feb 19, 2026ROIV Roivant Sciences LtdSold$38.4M
Feb 19, 2026ROIV Roivant Sciences LtdBought (not open market)—
Dec 24, 2025ROIV Roivant Sciences LtdSold (not open market)$1.5M
Dec 24, 2025ROIV Roivant Sciences LtdSold (not open market)—
Dec 23, 2025ROIV Roivant Sciences LtdBought (not open market)$3.9M

Companies traded

  • IMVT Immunovant, Inc: 1 buy, last Apr 7, 2026
  • ROIV Roivant Sciences Ltd: 3 sales, last Mar 31, 2026
  • ABUS Arbutus Biopharma Corp: other filings, last May 23, 2024
  • SIOX Sio Gene Therapies Inc: other filings, last Apr 15, 2021
  • AXGT Axovant Gene Therapies Ltd: other filings, last Apr 15, 2020
  • MYOV Myovant Sciences Ltd: other filings, last Aug 23, 2019
  • UROV Urovant Sciences Ltd: other filings, last Jul 9, 2019
  • AXON Axovant Sciences Ltd: other filings, last Oct 15, 2018

Get free alerts when Frank Torti files a new trade →